CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty Insights From the OPEN-CTO Registry The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the Week Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent 5-Year Outcomes of the Randomized BIOFLOW-II Trial Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials

Guideline2013 Oct;34(38):2949-3003.

JOURNAL:Eur Heart J. Article Link

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology

Task Force Members, Montalescot G, Sechtem U et al. Keywords: Angina pectoris; Coronary revascularization; Guidelines; Myocardial ischaemia; Risk factors; Stable coronary artery disease; anti-ischaemic drugs

FULL TEXT PDF